UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057346
Receipt number R000065529
Scientific Title A multicenter, open-label, single-arm interventional clinical study on handwriting training focusing on pen pressure for patients with Parkinson's disease
Date of disclosure of the study information 2025/03/20
Last modified on 2025/03/19 18:23:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter, open-label, single-arm interventional clinical study on handwriting training focusing on pen pressure for patients with Parkinson's disease

Acronym

A multicenter, open-label, single-arm interventional clinical study on handwriting training focusing on pen pressure for patients with Parkinson's disease

Scientific Title

A multicenter, open-label, single-arm interventional clinical study on handwriting training focusing on pen pressure for patients with Parkinson's disease

Scientific Title:Acronym

A multicenter, open-label, single-arm interventional clinical study on handwriting training focusing on pen pressure for patients with Parkinson's disease

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether writing pressure-aware writing training for PD patients changes (improves) dysgraphia, PD symptoms, PD-related writing pressure and writing, and PD-related symptoms.

Basic objectives2

Others

Basic objectives -Others

Improvement of handwriting through pressure-conscious calligraphy training

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Investigation of improvement of handwriting through pressure-conscious writing training

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Other

Interventions/Control_1

1) Pre-test (30 minutes): Confirmation of writing style and measurement of various evaluation indices such as writing pressure
2) Writing training with an awareness of writing pressure (60 minutes): Writing training with an awareness of writing pressure
3) Post-training test (30 min): Confirmation of handwriting after training and measurement of various evaluation indices

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

55 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Age between 55 and 65 years old at the time of consent.
2) Patients who have been diagnosed with Parkinson's disease (clinically established or clinically almost certain) according to the 'MDS-PD Criteria (2015)' or who meet the diagnostic criteria for prodromal stage Parkinson's disease.
3) Gender: any gender
4) Inpatient/outpatient:No preference
5) Patients who have been fully informed about their participation in the study, and who have given their free and voluntary written consent based on their full understanding of the study.
6) Patients who are able to write.

Key exclusion criteria

1) Patients who are unable to follow the procedures of this study
2) Patients with writing difficulties
3) Patients with any of the following complications
Serious complications (cerebrovascular disease, cardiac disease, chronic respiratory disease, uncontrolled hypertension, diabetes mellitus, etc.)
4) Other patients deemed inappropriate as research subjects by the principal investigator.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Wataru
Middle name
Last name Sako

Organization

Juntendo University Hospital

Division name

Department of Neurology

Zip code

113-8431

Address

3-1-3 Hongo Bunkyo-ku, Tokyo

TEL

03-3813-3111

Email

w.sako.fn@juntendo.ac.jp


Public contact

Name of contact person

1st name Wataru
Middle name
Last name Sako

Organization

Juntendo University Hospital

Division name

Department of Neurology

Zip code

113-8431

Address

3-1-3 Hongo Bunkyo-ku, Tokyo

TEL

03-3813-3111

Homepage URL


Email

w.sako.fn@juntendo.ac.jp


Sponsor or person

Institute

other

Institute

Department

Personal name



Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Faculty of Medicine, Juntendo University

Address

3-1-3 Hongo,Bunkyo-ku,Tokyo

Tel

03-3813-3111

Email

hongo-rinri@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 12 Month 09 Day

Date of IRB

2025 Year 02 Month 07 Day

Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 19 Day

Last modified on

2025 Year 03 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065529